Print Print page | Email Email page      
    

About Us

Corporate Overview

  • Platform Stem Cell Technology
           Tissue Repair Cell (TRC) technology

  • Over 375 Patients Treated to Date

  • Active Clinical Trial Program

  • Comprehensive Patent Portfolio
           U.S. Patents – 26 issued, 4 pending
           Foreign Patents – 41 issued, 4 pending

  • Headquarters – Ann Arbor, Michigan
 
Home | Forward Looking Statement Aastrom Biosciences, Inc. · Tel: 734-930-5555     © 2010